Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
CVS Health
CVS
|
+$349M |
| 2 |
Nike
NKE
|
+$280M |
| 3 |
Home Depot
HD
|
+$262M |
| 4 |
Amazon
AMZN
|
+$167M |
| 5 |
Mastercard
MA
|
+$166M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$232M |
| 2 |
Coca-Cola
KO
|
+$226M |
| 3 |
Johnson & Johnson
JNJ
|
+$213M |
| 4 |
Meta Platforms (Facebook)
META
|
+$203M |
| 5 |
B
Barrick Mining Corporation
B
|
+$193M |
Sector Composition
| 1 | Technology | 13.83% |
| 2 | Healthcare | 12.18% |
| 3 | Financials | 11.43% |
| 4 | Industrials | 8.95% |
| 5 | Consumer Discretionary | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NSM
2901
DELISTED
Nationstar Mortgage Holdings
NSM
| $348K | ﹤0.01% |
30,900
-154,100
| -83% | -$1.74M |
|
|
VOXX
2902
DELISTED
VOXX International Corporation Class A
VOXX
| $347K | ﹤0.01% |
124,400
+64,500
| +108% | +$180K |
|
|
MCUR
2903
DELISTED
Macrocure Ltd.
MCUR
| $346K | ﹤0.01% |
243,900
+57,400
| +31% | +$81.4K |
|
2904
Duluth Holdings
DLTH
$133M
| $345K | ﹤0.01% |
+14,100
| New | +$345K |
|
2905
Tecnoglass
TGLS
$3.46B
| $345K | ﹤0.01% |
30,520
-32,880
| -52% | -$372K |
|
2906
Veritex Holdings
VBTX
$1.88B
| $344K | ﹤0.01% |
21,500
+1,800
| +9% | +$28.8K |
|
|
AIFU
2907
AIFU Inc. Class A Ordinary Share
AIFU
$85.8M
| $344K | ﹤0.01% |
2,420
+1,674
| +224% | +$238K |
|
|
ASM
2908
Avino Silver & Gold Mines
ASM
$642M
| $343K | ﹤0.01% |
+141,021
| New | +$343K |
|
2909
Phio Pharmaceuticals
PHIO
$13.3M
| $342K | ﹤0.01% |
2
| – | – |
|
2910
Townsquare Media
TSQ
$115M
| $342K | ﹤0.01% |
43,300
+32,100
| +287% | +$254K |
|
2911
JD.com
JD
$48.8B
| $340K | ﹤0.01% |
+16,000
| New | +$340K |
|
|
BPTH
2912
DELISTED
Bio-Path Holdings Inc
BPTH
| $340K | ﹤0.01% |
43
+14
| +48% | +$111K |
|
|
VRML
2913
DELISTED
Vermillion, Inc.
VRML
| $339K | ﹤0.01% |
305,000
-7,400
| -2% | -$8.23K |
|
2914
Ceco Environmental
CECO
$1.68B
| $338K | ﹤0.01% |
38,683
-107,700
| -74% | -$941K |
|
2915
Veracyte
VCYT
$2.51B
| $336K | ﹤0.01% |
66,800
+29,426
| +79% | +$148K |
|
|
MNI
2916
DELISTED
The McClatchy Company Class A Common Stock
MNI
| $335K | ﹤0.01% |
22,930
+7,200
| +46% | +$105K |
|
2917
EVI Industries
EVI
$360M
| $334K | ﹤0.01% |
87,100
-100
| -0.1% | -$383 |
|
|
IMUC
2918
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
| $334K | ﹤0.01% |
36,313
-607
| -2% | -$5.58K |
|
|
ENFY
2919
Enlightify Inc.
ENFY
$16.4M
| $333K | ﹤0.01% |
20,875
+3,858
| +23% | +$61.5K |
|
2920
Weibo
WB
$2.92B
| $332K | ﹤0.01% |
11,700
-11,800
| -50% | -$335K |
|
|
STLY
2921
DELISTED
Stanley Furniture Co Inc
STLY
| $331K | ﹤0.01% |
135,127
-2,073
| -2% | -$5.08K |
|
|
FGNX
2922
FG Nexus Inc. Common Stock
FGNX
$9.53M
| $329K | ﹤0.01% |
2,060
+392
| +24% | +$62.6K |
|
2923
NL Industries
NL
$304M
| $327K | ﹤0.01% |
127,100
+8,701
| +7% | +$22.4K |
|
|
RTC
2924
DELISTED
Baijiayun Group
RTC
| $324K | ﹤0.01% |
15,885
+120
| +0.8% | +$2.45K |
|
|
CGNT
2925
DELISTED
Cogentix Medical, Inc.
CGNT
| $324K | ﹤0.01% |
336,663
+17,500
| +5% | +$16.8K |
|